Invention Grant
- Patent Title: Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
-
Application No.: US16556055Application Date: 2019-08-29
-
Publication No.: US10981905B2Publication Date: 2021-04-20
- Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Christoph Martin Dehnhardt , Thilo Focken , Michael Edward Grimwood , Qi Jia , Verner Alexander Lofstrand , Shaoyi Sun , Steven Sigmund Wesolowski , Michael Scott Wilson , Alla Yurevna Zenova
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; C07D417/14 ; C07D401/12 ; C07D401/14 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D487/08
Abstract:
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
Public/Granted literature
- US20200157089A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Public/Granted day:2020-05-21
Information query
